Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
The American Journal of Medicine|May 10, 1976
Desquamative interstitial pneumonia following long-term nitrofurantoin therapyR C Bone, J Wolfe, R E Sobonya, et al.
Critical Care Medicine|November 1, 1988
Effects of ibuprofen on neutrophil function and acute lung injury in canine endotoxin shockR A Balk, R F Jacobs, A F Tryka, et al.
JAMA|May 8, 1991
An experiment in medical education. A critical analysis using traditional criteriaL J Goodman, E E Brueschke, R C Bone, et al.
The New England Journal of Medicine|September 10, 1987
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shockR C Bone, C J Fisher, T P Clemmer, et al.
The Journal of Trauma|April 1, 1992
The effects of prostaglandin E1 on non-pulmonary organ function during clinical acute respiratory failure. The Prostaglandin E1 Study GroupG J Slotman, M D Kerstein, R C Bone, et al.
Chest|August 1, 1990
Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study GroupH J Silverman, G Slotman, R C Bone, et al.
The American Review of Respiratory Disease|January 1, 1988
Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndromeJ W Cox, N A Andreadis, R C Bone, et al.
Seminars in Thrombosis and Hemostasis|May 14, 1998
Therapeutic use of antithrombin concentrate in sepsisR Balk, T Emerson, F Fourrier, et al.
Chest|June 1, 1992
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care MedicineR C Bone, R A Balk, F B Cerra, et al.
Critical Care Medicine|January 1, 1994
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trialC J Fisher, G J Slotman, S M Opal, et al.
Pageof 16